Intravenous immunoglobulins in dermatology. Part 1: biological mechanisms and methods of administration

8Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Intravenous immunoglobulin (IVIg) is a solution of human IgG, salt, sugars and solvents, which is used to treat a multitude of diseases. Although IVIg has been known to treat many diseases safely and successfully, there are relatively few supporting randomized controlled trials. In this article, we review the biological mechanisms of IVIg in dermatological disorders and the practicalities of its use, including its mechanism of action, dosing, availability, costs and adverse effects.

Cite

CITATION STYLE

APA

Forbat, E., Ali, F. R., & Al-Niaimi, F. (2018, July 1). Intravenous immunoglobulins in dermatology. Part 1: biological mechanisms and methods of administration. Clinical and Experimental Dermatology. Blackwell Publishing Ltd. https://doi.org/10.1111/ced.13553

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free